The First Macrolide-Resistant Bordetella pertussis Strains Isolated From Iranian Patients

Fereshteh Shahcheraghi1, Masoumeh Nakhost Lotfi1, Vajiheh Sadat Nikbin1

  • 1Department of Bacteriology, Pertussis Reference Laboratory, Microbiology Research Center, Pasteur Institute of Iran, Tehran, IR Iran.

Abstract

Insights

This study investigated Bordetella pertussis antibiotic resistance in Iran. Azithromycin is recommended for treating whooping cough, as most strains showed susceptibility, indicating clonal spread.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Whooping cough (pertussis) remains a significant global health concern, particularly for children.
  • Emerging macrolide-resistant Bordetella pertussis strains pose a growing threat worldwide.
  • Limited data existed on macrolide resistance in Iranian clinical isolates.

Purpose of the Study:

  • To assess the antibiotic susceptibility of Bordetella pertussis isolates in Iran.
  • To investigate the prevalence of macrolide resistance in Bordetella pertussis.
  • To determine the clonal relatedness of isolated Bordetella pertussis strains.

Main Methods:

  • Antibiotic susceptibility testing using Minimum Inhibitory Concentration (MIC) for erythromycin, azithromycin, and clarithromycin.
  • Analysis of 779 nasopharyngeal swabs for Bordetella pertussis isolation.
  • Pulsed-field Gel Electrophoresis (PFGE) to characterize strain relatedness.

Main Results:

  • Out of 779 samples, 11 (1.4%) were positive for Bordetella pertussis.
  • Two isolates exhibited high Minimum Inhibitory Concentration (MIC) values for erythromycin and clarithromycin.
  • Pulsed-field Gel Electrophoresis (PFGE) identified 6 distinct strain profiles (A-F).

Conclusions:

  • Azithromycin demonstrates efficacy and is a suitable treatment option for Bordetella pertussis infections in Iran.
  • The study revealed clonal relationships among isolates, suggesting the circulation of common Bordetella pertussis strains within Iran.

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
160
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
180
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
74
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
73
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
52
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K